The U.S. Food and Drug Administration approved the use of a new cancer treatment pill on Wednesday. Rasonque, manufactured by Revolution Medicines in California, is an inhibitor for the most common type of pancreatic cancer. The tablet, which is taken once daily, targets multiple forms of a protein called RAS that drives tumor growth. In […]
Go to Source
https://intellinews.org/2026/08/26/fda-approves-once-daily-pill-for-deadly-cancer-after-patients-survival-rates-nearly-double/